Centerpoint Advisors’s Abiomed Inc ABMD Stock Holding History

Centerpoint Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$246K	–	542
2022 Q3	$246K	Hold	1,000	–	–	0.13%	69
2022 Q2	$248K	Hold	1,000	–	–	0.13%	72
2022 Q1	$331K	Hold	1,000	–	–	0.15%	60
2021 Q4	$359K	Hold	1,000	–	–	0.16%	61
2021 Q3	$326K	Hold	1,000	–	–	0.16%	61
2021 Q2	$312K	Hold	1,000	–	–	0.15%	64
2021 Q1	$319K	Hold	1,000	–	–	0.19%	36
2020 Q4	$324K	Hold	1,000	–	–	0.21%	34
2020 Q3	$277K	Sell	1,000 -21	-2%	-$6.05K	0.21%	38
2020 Q2	$247K	Buy	1,021 +21	+2%	+$4.22K	0.2%	40
2020 Q1	$145K	Hold	1,000	–	–	0.14%	43
2019 Q4	$171K	Hold	1,000	–	–	0.13%	45
2019 Q3	$178K	Hold	1,000	–	–	0.14%	42
2019 Q2	$260K	Hold	1,000	–	–	0.21%	39
2019 Q1	$286K	Hold	1,000	–	–	0.24%	34
2018 Q4	$325K	Hold	1,000	–	–	0.31%	30
2018 Q3	$450K	Hold	1,000	–	–	0.36%	21
2018 Q2	$409K	Hold	1,000	–	–	0.34%	22
2018 Q1	$291K	Hold	1,000	–	–	0.25%	32
2017 Q4	$187K	Buy	+1,000	New	+$187K	0.17%	37

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Centerpoint Advisors's ABMD Position: Q4 2022 in Review

Centerpoint Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,000 shares — an estimated $246K sold.

Centerpoint Advisors first reported a position in ABMD in Q4 2017 and held it in 20 quarters. The position peaked at $450K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Centerpoint Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Centerpoint Advisors sold 1,000 Abiomed Inc shares in Q4 2022, an estimated $246K.
Centerpoint Advisors first reported a position in Abiomed Inc in Q4 2017 and held it in 20 quarters.
Centerpoint Advisors's Abiomed Inc position peaked at $450K in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Centerpoint Advisors's 13F filing for Q4 2022, filed 24 Jan 2023.